Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
Resource Type
Article
Authors
Kelley, Robin Kate ; Rimassa, Lorenza ; Cheng, Ann-Lii ; Kaseb, Ahmed ; Qin, Shukui ; Zhu, Andrew X ; Chan, Stephen L ; Melkadze, Tamar ; Sukeepaisarnjaroen, Wattana ; Breder, Valery ; Verset, Gontran ; Gane, Edward ; Borbath, Ivan ; Rangel, Jose David Gomez ; Ryoo, Baek-Yeol ; Makharadze, Tamta ; Merle, Philippe ; Benzaghou, Fawzi ; Banerjee, Kamalika ; Hazra, Saswati ; Fawcett, Jonathan ; Yau, Thomas
Source
In The Lancet Oncology August 2022 23(8):995-1008
Subject
Primary Research Articles
Language
ISSN
1470-2045